Skip to main content
. 2022 Jan 4;16(11):2117–2134. doi: 10.1002/1878-0261.13146

Fig. 2.

Fig. 2

TGF‐β and PD‐L1 signaling pathways are implicated in overlapping but nonredundant tumor survival mechanisms, such that simultaneous inhibition may enhance antitumor activity over inhibition of either pathway alone. PD‐1, programmed death 1; PD‐L1, programmed death ligand 1; TGF, transforming growth factor.